Xiaoming Li
- Epidemiology top 5%
- Molecular Biology
- Hepatology top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Physiology
- Topics
- Liver Disease Diagnosis and Treatment (18 papers)Diet, Metabolism, and Disease (5 papers)Peroxisome Proliferator-Activated Receptors (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoming Li
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 115
- Epidemiology 537
- Molecular Biology 246
- Hepatology 193
- Endocrinology, Diabetes and Metabolism 184
- Physiology 179
Countries citing papers authored by Xiaoming Li
This map shows the geographic impact of Xiaoming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Li more than expected).
Fields of papers citing papers by Xiaoming Li
This network shows the impact of papers produced by Xiaoming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Li. The network helps show where Xiaoming Li may publish in the future.
Co-authorship network of co-authors of Xiaoming Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Li. A scholar is included among the top collaborators of Xiaoming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Li. Xiaoming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 14 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 22 | |
| 10 | 1 | |
| 11 | Effect of recombinant human granulocyte-colony stimulating factor on chemotherapy period infection and immune function of patients with gastric cancer chemotherapy. | 1 |
| 12 | 22 | |
| 13 | 25 | |
| 14 | 25 | |
| 15 | 10 | |
| 16 | 21 | |
| 17 | 48 | |
| 18 | Investigation on Optimal Allocation of Mass Flow and Direction for Binary Cooling Turbine Test Blades | 1 |
| 19 | The study of tinctura Xianchen Fenci Jing in anti-inflammation | 1 |
| 20 | A Range Estimation on Priority Vectors in AHP | 0 |
About Xiaoming Li
Xiaoming Li is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Hepatology (193 citations), Epidemiology (537 citations) and Endocrinology, Diabetes and Metabolism (184 citations). Xiaoming Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xin Gao, Mingfeng Xia, Patrick Tso, Wanyuan He, Hongmei Yan, Zongfang Li, Min Xu, Mubing Duan, Liang Li and An Jiang. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.